ArticleNature communications2025
Molecular Motif Learning as a pretraining objective for molecular property prediction.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- KAN-GIN: Adaptive Nonlinear Molecular Representation Learning for Drug-Target Affinity Prediction.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Molecular Motif Learning as a pretraining objective for molecular property prediction.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular property prediction is crucial for drug discovery in biopharmaceuticals since it helps identify promising compounds, optimizing the efficacy of developing new therapies. Despite its importance, existing deep learning-based methods for this task are often incongruous with fundamental chemical properties. Here we show that an unsupervised pretraining approach, Molecular Motif Learning (MotiL), learns molecular representations that preserve both whole-molecule structure and motif-level information directly from native molecular graphs. MotiL produces representations that group small molecules sharing a common core structure (i.e., scaffold) and proteins with related three-dimensional structures and functions. We evaluated MotiL on at least 16 molecule benchmarks, and uncovered that it captures analogous graph representations not only for small molecules with the same scaffold but also for protein macromolecules with similar structures and overlapping chemical functions such as tRNA binding. These informative representations empower MotiL to surpass the accuracy of state-of-the-art contrastive or predictive methods in the prediction of molecular properties like blood brain barrier permeability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.